Daratumumab, Pomalidomide, and Dexamethasone (DPd) in Relapsed/Refractory Light Chain Amyloidosis Patients Previously Exposed to Daratumumab
Clinical trial NCT04270175 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04270175
- Sponsor
- Weill Medical College of Cornell University
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-14
- Primary completion
- 2027-01-01
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.